General information
Absorbable sutures includes:
- Sutures (thread mounted in a needle) for joining the edges of a wound or incision by stitching.
- Ligatures (thread without needle) used to tie up a bleeding artery.
Sutures for gastrointestinal, paediatric and general surgery:
|
MSNSABSB20R2: |
ABS, BRAID. VI, 2-0 US/3 E, 90cm, n. &fraq12;-25.9mm round, 243 |
|
MSNSABSB2R4: |
ABS, BRAID. VI, 2 US/5 E, 90cm, n. &fraq12;-48mm round, 372 |
|
MSNSABSB30R2: |
ABS, BRAID. VI, 3-0 US/2 E, 70cm, n. &fraq12;-21.8mm round, 311 |
Sutures for urology and plastic surgery: Gauge USP 4-0:
|
MSNSABSB30R1: |
ABS, BRAIDED VI, 3-0 US/2 E, 70cm, n. &fraq12;-18.5mm round,2150 |
|
MSNSABSB40R1: |
ABS, BRAIDED VI, 4-0 US/2 E, 70cm, n. &fraq12;-18.5mm round,2140 |
Sutures for suturing muscles and fascia: Gauge USP 2, 1 and 0 (size 2 is also for suturing liver wounds
|
MSNSABSB2R4: |
ABS, BRAIDED VI, 2 US/5 E, 90cm, n. &fraq12;-48mm round, 372 |
|
MSNSABSB2RL: |
ABS, BRAIDED VI, 2 US/5 E, 75cm, n. 3/8 -85mm r., liver |
|
MSNSABSB0R3: |
ABS, BRAIDED VI, 0 US/3.5 E, 90cm, n. &fraq12;-36.4mm round, 346 |
|
MSNSABSB1R3: |
ABS, BRAIDED VI, 1 US/4 E, 90cm, n. &fraq12;-39.9mm round, 359 |
Ligatures for tying off bleeding vessels: Gauge USP 0, 2-0 and 3-0
|
MSNSABSBL0: |
ABS, BRAIDED VI., LIGATURE 0 US/3.5 E, 140cm, ref. 616 |
|
MSNSABSBL20: |
ABS, BRAIDED VI., LIGATURE 2-0 US/3 E, 140cm, ref. 615 |
|
MSNSABSBL30: |
ABS, BRAIDED VI., LIGATURE 3-0 US/2 E, 140cm, ref. 614 |
Specifications
|
Materials: |
Thread: polyglactin 910 (copolymer composed of 90% glycoside and 10% L-lacticide) |
|
|
Thread coating: mixture of equal parts copolymer of glycoside and lactide (polyglactin 370) and calcium stearate. |
|
|
Needle: treated stainless steel. |
A suture holds a wound together, in good apposition, until such time as the natural healing process is sufficiently well-advanced as to render support from suture materials unnecessary and redundant.
Thread: The absorbable synthetic sterile thread polyglactin 910 (e.g., EthiconVicryl a violet-dyed braided suture) elicits a minimal acute inflammatory reaction in tissue and minimal ingrowths of fibrous connective tissue.
Polyglactin 910 thread progressively loses tensile strength; absorption eventual occurs via hydrolysis: a process in which the copolymer degrades to glycolic and lactic acids that are subsequently absorbed and metabolized in the body.
Coating: Braided material is often coated to decrease capillarity and to create a smooth surface. Absorption begins as a loss of tensile strength followed by a loss of mass.
Vicryl; Indicated for use in general soft tissue approximation and/or ligation, including ophthalmic procedures, but not for use in vascular or neurological tissues.
|
Tensile strength: |
Post implantation |
|
|
- 50% at 21 days |
|
|
- 0% at 35 days |
|
Absorption: |
Essentially completed between 56 and 70 days. |
Vicryl Rapid: Indicated for use in soft tissue approximation of the skin and mucosa where only short-term support to a wound is required. Not intended for use in ligation, ophthalmic, cardiovascular or neurological procedures.
|
Tensile strength: |
Post implantation |
|
|
-50% at 5 days |
|
|
-0% at 12 days |
|
Absorption: |
Essentially completed between 35 and 42 days. |
The braid’s coated multifilament ensures ease of handling and knotting; the special lubricant coating remains bonded to the material throughout its use, ensuring the sutures smooth passage through tissue and easy knot tie-down.
Thread Gauge: as indicated in the Unite States Pharmacopoeia (USP) and the European pharmacopoeia (EP).
|
Gauges for absorbable and non-absorbable synthetic materials
|
|
USP size code
|
EP size code
|
Diameter
min. max. |
|
5-0 |
1 |
0.10 – 0.14 |
|
4-0 |
1.5 |
0.15 – 0.19 |
|
3-0 |
2 |
0.20 – 0.24 |
|
2-0 |
2.5 |
0.25 – 0.29 |
|
0 |
3 |
0.30 – 0.39 |
|
1 |
4 |
0.40 – 0.49 |
|
2 |
5 |
0.50 – 0.59 |
|
Needles: |
- Type: eyeless with attached needle, thread mounted on needle |
|
|
- Point: round (non-cutting) has no edges that can cut through tissue; it is used for suturing easily torn tissues; i.e., peritoneum or intestine. |
|
|
- Shape: the degree of curvature is described in terms of circumference: &fraq12; to 3/8 of a circle. |
|
|
- Length: available in different lengths 18-48mm. |
Key to read absorbable suture description
ABS, BRAIDED VI, 2-0 US/3 E, 90 cm, n. &fraq12;-25.9mm round, 243
|
General description: |
Absorbable suture |
ABS |
|
Thread type |
Braided |
BRAID |
|
Registered name: |
Vicryl |
VI |
|
Thread Gauge: |
US Pharmacopoeia |
2-0 USP |
|
|
European pharmacopoeia |
3 EP |
|
Tread length: |
|
90cm |
|
Needle: |
|
n. |
|
|
Shape: &fraq12; circle |
&fraq12; |
|
|
Length: |
25.9 |
|
|
Point: |
rounded (r.) |
|
Manufacturer code Nr: |
example: Ethicon V 243 H |
243 |
Tensile strength post implantation is 0% at 35 days.
Absorption is completed between 56 and 70 days.
MSNSABSB2R4
MSNSABSB2RL
MSNSABSB0R3
MSNSABSB1R3
MSNSABSB20R2
MSNSABSB2R4
MSNSABSB30R2
MSNSABSBL0
MSNSABSBL20
MSNSABSBL30
Vicryl Rapid tensile strength post implantation is 0 % at 12 days.
Absorption is completed between 32 and 45 days.
MSNSABSB30R1
MSNSABSB40R1
Liver suture has a 3/8 needle with a blunt point
MSNSABSB2RL (Ref ASSUT 46468)
|
Unit presentation: |
1 suture with needle or 1 ligature, sterile, double packaging, single-use. |
|
Packaging: |
Box containing 36 individually-packaged sutures or ligatures marked with the following: |
|
|
- Product name and reference number. |
|
|
- Product description and thread composition. |
|
|
- Thread gauge size in USP and EP. |
|
|
- Needle type and size. |
|
|
- Sterile - Sterilization method (ethylene oxide). |
|
|
- Expiration date, lot and batch number. |
|
|
- CE mark and reference number of notifying body. |
|
Storage: |
Maximum temperature 25°C, protect from direct sunlight. |
|
Comments: |
Do not re-sterilize: once opened discard all unused sutures and ligatures. |
|
|
Re-sterilizing causes materials to lose their strength and pliability. |
|
Other:
|
Suture quality must meet the characteristics and tests described in the EU and US pharmacopoeias.
Must comply with European Medical Device Directive 93/42/EEC or American Directives 21CFR820. |